We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
U.S-based biotech company IdentifySensors, developer of graphene-based biosensors, has announced plans to commercialize its disease testing technology and seek new funding in 2026.
